Online inquiry

IVTScrip™ mRNA-Human AMER3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21449MR)

This product GTTS-WK21449MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AMER3 protein. This product can be used in Secretory progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001105193.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 205147
UniProt ID Q8N944
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AMER3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21449MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK27163MR IVTScrip™ mRNA-Human ARNTL, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARNTL
GTTS-WK24680MR IVTScrip™ mRNA-Human ARHGAP1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARHGAP1
GTTS-WK13368MR IVTScrip™ mRNA-Human ACTR10, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ACTR10
GTTS-WK9498MR IVTScrip™ mRNA-Human ADAMTS1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS1
GTTS-WK23785MR IVTScrip™ mRNA-Human ARHGAP18, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP18
GTTS-WK23228MR IVTScrip™ mRNA-Human ARID5B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARID5B
GTTS-WK19997MR IVTScrip™ mRNA-Human ANKRD10, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD10
GTTS-WK6243MR IVTScrip™ mRNA-Human CD133, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA CD133
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →